InvestorsHub Logo
Followers 0
Posts 120
Boards Moderated 0
Alias Born 04/06/2020

Re: None

Tuesday, 04/18/2023 7:02:49 PM

Tuesday, April 18, 2023 7:02:49 PM

Post# of 36600
Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

April 18, 2023 18:44 ET

https://www.globenewswire.com/news-release/2023/04/18/2649628/0/en/Revive-Therapeutics-Provides-Update-of-Phase-3-Clinical-Study-for-Bucillamine-in-the-Treatment-of-COVID-19.html